@article{Menzies-Gow:2019:10.1164/rccm.201902-0321UP,
author = {Menzies-Gow, A and McBrien, CN and Baker, JR and Donnelly, LE and Cohen, RT},
doi = {10.1164/rccm.201902-0321UP},
journal = {American Journal of Respiratory and Critical Care Medicine},
pages = {14--19},
title = {Update in asthma/airway inflammation 2018},
url = {http://dx.doi.org/10.1164/rccm.201902-0321UP},
volume = {200},
year = {2019}
}

Download

TY  - JOUR
AB  - Throughout 2018, the publications of the AJRCCM and associated ATS journals have continued to focus on  the  individual  and  societal  impact  of  asthma  and  the  challenges  involved  in  managing  this prevalent,  but  heterogeneous,  condition.    Asthma  remains  the  most  common  chronic  respiratory condition with ongoing significant unmet need at all levels of severity. The cardinal features of asthma, i.e. that it affects a significant proportion of all agegroups, but generates highly individual effects on health  and  socioeconomic  factors,  have  hampered  previous  attempts  to  gauge  its  true  cost  at  a population level.  Nurmagambetov et al. approached this task by utilising data from the 20082013 household component of the Medical Expenditure Panel Survey, examining a total sample size of more than 200,000 persons (more than 10,000 of whom had ‘treated asthma’)[1].  Application of a twopart regression model indicated the cost of asthma in the USA in 2013 to be $81.9 billion, underlining the  huge potential  for improvements in asthma care  to benefit individuals and populations in multiple aspects, including financially.
AU  - Menzies-Gow,A
AU  - McBrien,CN
AU  - Baker,JR
AU  - Donnelly,LE
AU  - Cohen,RT
DO  - 10.1164/rccm.201902-0321UP
EP  - 19
PY  - 2019///
SN  - 1073-449X
SP  - 14
TI  - Update in asthma/airway inflammation 2018
T2  - American Journal of Respiratory and Critical Care Medicine
UR  - http://dx.doi.org/10.1164/rccm.201902-0321UP
UR  - https://www.ncbi.nlm.nih.gov/pubmed/31026407
UR  - http://hdl.handle.net/10044/1/70131
VL  - 200
ER  - 

Download